Use the Search Fields to Find Information
Page 4 of 333
Where Do Adults in the United States Obtain Cannabis? A Nationally Representative Study Examining the Relationships Between Sociodemographic Factors, Cannabis Use Characteristics and Sources of Cannabis
Please use this link to access this publication. Abstract Objective: Characterization of population subgroups based on where they acquire cannabis is unexplored. We examine relationships
March 10, 2025
When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services
Abstract Cannabis use is a modifiable risk factor for the development and exacerbation of mental illness. The strongest evidence of risk is for the development
May 16, 2025
What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review
Please use this link to access this publication. Abstract Purpose of Review The purpose of the study was to examine the published evidence on the
November 4, 2024
What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
Please use this link to access this publication. Abstract Aims To examine changes in the evidence on the adverse health effects of cannabis since 1993.
October 7, 2024
Weight loss outcomes are not compromised in bariatric patients using cannabis
Please use this link to access this publication: https://link.springer.com/article/10.1007/s00464-022-09453-x Abstract Background The legalization of cannabis in several states has led to increased documented use in the
November 30, 2023
Weeding through the haze: a survey on cannabis use among people living with Parkinson’s disease in the US
Abstract Symptomatic management of Parkinson’s disease (PD) is complex and many symptoms, especially non-motor symptoms, are not effectively addressed with current medications. In the US,
July 25, 2025
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se
Abstract Cannabidiol (CBD) is a non-psychoactive, well-tolerated, anticonvulsant plant cannabinoid, although its mechanism(s) of seizure suppression remains unknown. Here, we investigate the effect of CBD
September 19, 2019
Venous thromboembolism and cannabis consumption, outcomes among hospitalized patients in the United States: A nationwide analysis
Please use this link to access this publication. Abstract Venous Thromboembolism (VTE) carries significant clinical implications, and with the rise in cannabis consumption, its potential influence
December 6, 2023
Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol
Abstract Although natural sesame oil has been shown to facilitate the lymphatic delivery and oral bioavailability of the highly lipophilic drug cannabidiol (CBD), considerable
July 5, 2022
Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
Abstract Our study aimed to examine the endothelium (vascular)-protecting effects of chronic cannabidiol (CBD) administration (10 mg/kg once daily for 2 weeks) in aortas and
April 26, 2024
Page 4 of 333